BALSARI, ANDREA
 Distribuzione geografica
Continente #
AS - Asia 10.096
EU - Europa 9.640
NA - Nord America 9.502
SA - Sud America 885
AF - Africa 192
OC - Oceania 65
Continente sconosciuto - Info sul continente non disponibili 13
Totale 30.393
Nazione #
US - Stati Uniti d'America 9.111
CN - Cina 3.820
GB - Regno Unito 2.994
SG - Singapore 2.510
IT - Italia 1.730
DE - Germania 1.047
SE - Svezia 868
HK - Hong Kong 797
RU - Federazione Russa 681
BR - Brasile 630
IN - India 558
VN - Vietnam 508
BD - Bangladesh 493
FR - Francia 430
TR - Turchia 339
UA - Ucraina 338
KR - Corea 330
NL - Olanda 291
IE - Irlanda 263
JP - Giappone 254
CA - Canada 249
FI - Finlandia 236
ES - Italia 147
DK - Danimarca 140
EU - Europa 116
ID - Indonesia 110
PL - Polonia 109
CO - Colombia 93
GR - Grecia 92
BE - Belgio 87
MX - Messico 83
TW - Taiwan 67
AU - Australia 58
CI - Costa d'Avorio 56
AR - Argentina 55
PH - Filippine 39
PT - Portogallo 35
IR - Iran 34
EG - Egitto 28
IQ - Iraq 28
VE - Venezuela 27
ZA - Sudafrica 27
TH - Thailandia 26
CH - Svizzera 25
EC - Ecuador 22
AT - Austria 21
CL - Cile 21
LV - Lettonia 21
RO - Romania 21
MY - Malesia 19
KE - Kenya 18
SA - Arabia Saudita 18
MA - Marocco 16
PK - Pakistan 16
JO - Giordania 14
AE - Emirati Arabi Uniti 13
CR - Costa Rica 13
HU - Ungheria 13
IL - Israele 13
PE - Perù 13
UZ - Uzbekistan 12
CY - Cipro 9
DZ - Algeria 9
NP - Nepal 9
NG - Nigeria 8
UY - Uruguay 8
AZ - Azerbaigian 7
JM - Giamaica 7
SK - Slovacchia (Repubblica Slovacca) 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
KZ - Kazakistan 6
NO - Norvegia 6
PY - Paraguay 6
TT - Trinidad e Tobago 6
AL - Albania 5
BH - Bahrain 5
CZ - Repubblica Ceca 5
MO - Macao, regione amministrativa speciale della Cina 5
NZ - Nuova Zelanda 5
PA - Panama 5
RS - Serbia 5
TN - Tunisia 5
AM - Armenia 4
EE - Estonia 4
ET - Etiopia 4
GT - Guatemala 4
HN - Honduras 4
LA - Repubblica Popolare Democratica del Laos 4
LU - Lussemburgo 4
PR - Porto Rico 4
PS - Palestinian Territory 4
QA - Qatar 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
GE - Georgia 3
KG - Kirghizistan 3
KW - Kuwait 3
LB - Libano 3
LK - Sri Lanka 3
Totale 30.444
Città #
Southend 2.698
Singapore 1.425
Ashburn 833
Chandler 794
Hong Kong 688
Milan 665
Beijing 536
Seattle 487
San Jose 467
Fairfield 386
Frankfurt am Main 356
Princeton 336
Wilmington 328
Santa Clara 301
Dallas 295
Ann Arbor 293
Council Bluffs 269
Los Angeles 262
Dublin 254
Guangzhou 254
Jacksonville 235
Houston 202
Woodbridge 201
Shanghai 200
Nanjing 195
Redmond 179
Dearborn 172
Bengaluru 148
Mountain View 144
Cambridge 141
Lauterbourg 141
Boardman 128
Toronto 127
Ho Chi Minh City 125
Grafing 117
New York 109
Moscow 107
Hanoi 106
Des Moines 105
Sakarya 103
Tokyo 99
Buffalo 96
Athens 93
Hangzhou 91
Helsinki 89
Shenyang 87
Columbus 83
Tianjin 81
Warsaw 81
Phoenix 80
Shenzhen 79
Hefei 77
Jinan 77
Jakarta 74
Bogotá 73
The Dalles 73
Changsha 71
Serra 71
Andover 70
Zhengzhou 67
Wuhan 63
São Paulo 61
Rome 60
Somerville 59
Chengdu 58
Nanchang 57
Abidjan 56
Brussels 56
Seoul 54
Redwood City 48
Cangzhou 46
Istanbul 46
Berlin 44
Hebei 44
Fuzhou 43
Turin 39
Mumbai 37
Munich 37
Nuremberg 34
Dong Ket 33
Bitonto 32
Madrid 31
San Diego 31
Taipei 31
Sunnyvale 30
Naples 29
Ningbo 25
Atlanta 24
Palermo 24
San Francisco 24
Boston 23
Chicago 22
Haiphong 22
Jiaxing 22
London 22
Norwalk 22
Central 21
Kunming 21
Ottawa 21
Xiamen 21
Totale 17.997
Nome #
Gut microbiota condition the therapeutic efficacy of trastuzumab in HER2-positive breast cancer 3.112
Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-Small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade 972
Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases 521
Local Administration of Caloric Restriction Mimetics to Promote the Immune Control of Lung Metastases 381
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors 369
Anti-tumor activity of CpG-ODN aerosol in mouse lung metastases 353
The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy 339
Sodium glucose cotransporter 1 ligand BLF501 as a novel tool for management of gastrointestinal mucositis 315
Activation of enteroendocrine cells via TLRs induces hormone, chemokine, and defensin secretion 310
Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia 309
Mechanisms of hyperprogressive disease after immune checkpoint inhibitor therapy: what we (don’t) know 291
Increased sensitivity to chemotherapy induced by CpG-ODN treatment is mediated by microRNA modulation 289
HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy 284
Sodium-dependent glucose transporter-1 as a novel immunological player in the intestinal mucosa 278
Aerosol 1,25-dihydroxyvitamin D3 supplementation: A strategy to boost anti-tumor innate immune activity 276
Degranulation of paneth cells via toll-like receptor 9 273
Abstract in rivista: Role of Toll-like receptor 9 (TLR-9) in acute graft-versus-host disease 269
TLR9-agonists oppositely modulate DNA-repair genes in tumor versus immune cells and enhance chemotherapy effects 267
Poly(I:C) and CpG-ODN combined aerosolization to treat lung metastases and counter the immunosuppressive microenvironment 266
Exploiting poly(I:C) to induce cancer cell apoptosis 265
Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltration 264
miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response 264
Effect of adjuvant trastuzumab treatment in conventional clinical setting : an observational retrospective multicenter Italian study 264
Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of beta-defensin 2 via TLR2 and TLR4 263
Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition 251
Low molecular weight hyaluronic acid increases the self defence of skin epithelium by induction of β-defensin 2 via TLR2 and 4 248
High efficacy of CpG-ODN, cetuximab and cisplatin combination for very advanced ovarian xenograft tumors 247
Toll-like receptor 3 as a new marker to detect high risk early stage Non-Small-Cell Lung Cancer patients 241
Macrophages impair TLR9 agonist antitumor activity through interacting with the anti-PD-1 antibody Fc domain 240
Cross-talk among Toll-like receptors and their ligands 237
SGLT-1 as a novel immunological player in the intestinal mucosa 237
Activation of NK cell cytotoxicity by aerosolized CpG-ODN/poly(I:C) against lung melanoma metastases is mediated by alveolar macrophages 236
Caveolin-1 is expressed on multipotent cells of hair follicles and might be involved in their resistance to chemotherapy 235
Critical role of TLR9 in acute graft-versus-host disease 235
Antitumor efficacy of trastuzumab in nude mice orthotopically xenografted with human pancreatic tumor cells expressing low levels of HER-2/neu 231
CpG-oligodeoxynucleotides induce mobilization of hematopoietic progenitor cells into peripheral blood in association with mouse KC (IL-8) production 231
The influence of a fatty acids-free diet on breast cancer development in FVB/neu transgenic mice 231
EGFR through STAT3 modulates ΔN63α expression to sustain tumor-initiating cell proliferation in squamous cell carcinomas 229
Therapeutic synergism of gemcitabine and CpG-oligodeoxynucleotides in an orthotopic human pancreatic carcinoma xenograft 228
Ascites regression and survival increase in mice bearing advanced-stage human ovarian carcinomas and repeatedly treated intraperitoneally with CpG-ODN 228
Toll-like receptor agonists regulate β-defensin 2 release in hair follicle 223
Doxorubicin-induced alopecia is associated with sebaceous gland degeneration 222
The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1 220
Activation of smooth muscle and myenteric plexus cells of jejunum via Toll-like receptor 4 219
Influence of fatty acid-free diet on mammary tumor development and growth rate in HER-2/neu transgenic mice 218
CpG-Oligodeoxynucleotides activate tyrosinase-related protein 2-specific T lymphocytes but do not lead to a protective tumor-specific memory response 211
Induction of Paneth cell degranulation by orally administered toll-like receptor ligands 211
COMPUESTOS GLUCOPIRANOSIDOS UTILES PARA TRATAR DIABETES MELLITUS, ENFERMEDADES INFLAMATORIAS Y/O ALERGICAS, Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN 211
Aerosol delivery in the treatment of lung cancer 211
Antibody response after vaccination with antigen-pulsed dendritic cells 210
Allostimulation of patients' lymphocytes generates both T and NK-like cells cytotoxic for autologous melanoma 210
Epithelium-mesenchyme compartment interaction and oncosis on chemotherapy-induced hair damage 209
Antitumor activity of the TLR-5 ligand flagellin in mouse models of cancer 208
Combination of a CpG-oligodeoxynucleotide and a topoisomerase I inhibitor in the therapy of human tumour xenografts 208
Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress 208
CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts 208
Stimulation of TLRs by LMW-HA induces self-defense mechanisms in vaginal epithelium 206
Induction of pro-inflammatory programs in enteroendocrine cells by the Toll-like receptor agonists flagellin and bacterial LPS 204
Expression and prognostic significance of the autoimmune regulator gene in breast cancer cells 204
EGFR through STAT3 is a player in ΔNp63α expression and together sustain tumor-initiating cell proliferation in squamous cell carcinomas 200
Critical role of Toll-like receptor 9 in acute graft-versus-host disease 199
Compound with glycidic structure active in the therapy of systemic and local inflammation 199
Absence of the CD1 molecule up-regulates antitumor activity induced by CpG oligodeoxynucleotides in mice 198
Intestinal glucose uptake protects liver from lipopolysaccharide and d-galactosamine, acetaminophen, and alpha-amanitin in mice 197
Low molecular weight hyaluronic acid increases the self defence of skin epithelium by induction of β-defensin 2 via TLR2 and 4 197
Influence of lignans depletion on murine mammary gland morphology 197
Inhibition of DNA Repair Mechanisms and Induction of Apoptosis in Triple Negative Breast Cancer Cells Expressing the Human Herpesvirus 6 U94 196
Surveillance of spontaneous breast cancer metastasis by TRAIL-expressing CD34+ cells in a xenograft model 195
COMPOUNDS WITH GLYCIDIC STRUCTURE ACTIVE IN THE THERAPY OF SYSTEMIC AND LOCAL INFLAMMATION 194
PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells 194
Prevention of spontaneous mammary adenocarcinoma in HER-2/neu transgenic mice by foreign DNA 192
TLR3 expression induces apoptosis in human non‐small‐cell lung cancer 190
Reprogramming the lung microenvironment by inhaled immunotherapy fosters immune destruction of tumor 189
SGLT-1 as a novel immunological player in the intestinal mucosa 188
Influence of antibiotic treatment on breast carcinoma development in proto-neu transgenic mice 187
Apoptosis of hair follicle cells during doxorubicin-induced alopecia in rats 183
Ascites regression and survival increase in mice bearing advanced-stage human ovarian carcinomas and repeatedly treated intraperitoneally with CpG-ODN 182
Targeting Local Microbiota by Antibiotic Therapy Promotes Immunosurveillance against Cancer 182
Eradication of ovarian tumor xenografts by locoregional administration of targeted immunotherapy 180
Enhanced antitumour efficacy of gimatecan in combination with Bcl-2 antisense oligonucleotide in human melanoma xenografts 178
Fluctuation of HER2 expression in breast carcinomas during the menstrual cycle 178
Toll-like receptor agonists regulate beta-defensin 2 release in hair follicle 177
Dansyl C-glucoside as a novel agent against endotoxic shock 175
Apoptosis induction by trastuzumab: Possible role of the core biopsy intervention 170
Linking survival of HER2-positive breast carcinoma patients with surgical invasiveness 164
FOXP3 expression and overall survival in breast cancer 163
Topical administration of a doxorubicin-specific monoclonal antibody prevents drug-induced mouth apoptosis in mice 163
Maspin influences response to doxorubicin by changing the tumor microenvironment organization 161
USO DI MONOSACCARIDI COME IMMUNOMODULANTI 158
Low molecular weight hyaluronic acid increases the self defence of skin epithelium by induction of β-defensin 2 via TLR2 and 4 157
Cross-talk between tool-like receptors 5 and 9 on activation of human immune responses 155
COMPOSTI A STRUTTURA GLICOSIDICA ATTIVI NELLA TERAPIA DI STATI INFIAMMATORI LOCALI E SISTEMICI 155
Activity and resistance of trastuzumab according to different clinical settings 154
Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation 154
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score 153
Relevant role of repeated intreperitoneally treatment with CpG-ODN in mice bearing advanced-stage of human ovarian carcinomas 152
HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancer 151
AIRE is expressed and associated with good prognosis in breast cancer 150
Chemotherapy can enhance trastuzumab-mediated ADCC 143
Thymic function and immunoglobulin mutation genotype in B-cell chronic lymphocytic leukemia patients 140
Totale 25.790
Categoria #
all - tutte 80.765
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.765


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.748 220 174 148 188 260 219 232 235 255 181 228 408
2022/20232.835 341 326 229 311 322 482 69 169 305 57 110 114
2023/20242.150 137 219 153 217 341 127 121 159 83 147 216 230
2024/20254.332 201 386 161 398 285 237 213 486 319 343 383 920
2025/20268.393 784 453 781 641 877 568 1.051 454 899 543 776 566
2026/2027163 163 0 0 0 0 0 0 0 0 0 0 0
Totale 31.924